| Name | Nevadistinel | 
|---|
| Description | Nevadistinel (NYX-458; NYX-3054) is a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptor. Nevadistinel can be used to inhibit cognitive impairment associated with neurodegenerative diseases, such as mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, Lewy body disease[1]. | 
|---|---|
| Related Catalog | |
| Target | NMDA receptor[1] | 
| References | 
| Molecular Formula | C15H18N2O3 | 
|---|---|
| Molecular Weight | 274.32 |